'Azelaic Acid Esters In The Treatment Or Prevention Of Dyslipidemia And Associated Conditions' in Patent Application Approval Process (USPTO 20210251939)

Source :: Heart Disease Weekly. September 12, 2021, 188
Publication Year :: 2021
Abstract: 2021 SEP 12 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- A patent application by the inventors IZBICKA, Elzbieta (San Antonio, TX, US); STREEPER, Robert [...]

Subjects :: Fenofibrate -- Intellectual property
Esters -- Intellectual property
Antilipemic agents -- Intellectual property
Hypoglycemic agents
Cardiovascular diseases
Biotechnology industry
Pharmaceuticals and cosmetics industries
Health

Tools